International Journal of Medical and Health Sciences Research

Published by: Asian Medical Journals
Online ISSN: 2313-2752
Print ISSN: 2313-7746
Quick Submission    Login/Submit/Track

No. 1

An Observational Study Evaluating the Impact of Chikungunya Virus Infection on Oral Cavity and Temporomandibular Joint

Pages: 18-24
2018Find References

Finding References


An Observational Study Evaluating the Impact of Chikungunya Virus Infection on Oral Cavity and Temporomandibular Joint

Search :
Google Scholor
Search :
Microsoft Academic Search
Cite

DOI: 10.18488/journal.9.2018.51.18.24

Besalat Hussain , Fatima Mushtaq , Naima Javed , Affa Khan

Export to    BibTeX   |   EndNote   |   RIS

[1]         B. A. Goupil and C. N. Mores, "A review of Chikungunya virus-induced Arthralgia: Clinical manifestations, therapeutics, and pathogenesis," Open Rheumatology Journal, vol. 10, pp. 129-140, 2016. View at Google Scholar 

[2]         L. H. Calabrese, "Emerging viral infections and arthritis: The role of the rheumatologist," Nature Clinical Practice Rheumatology, vol. 4, pp. 2–3, 2008. View at Google Scholar | View at Publisher

[3]         W.H.O. Neglected Tropical Diseases, "Retrieved: http://www.who.int/ neglected_diseases/diseases/en/. [Accessed March 2016]," 2016.

[4]         M. F. Afzal, S. Q. Naqvi, M. A. Sultan, and A. Hanif, "Chikungunya fever among children presenting with nonspecific febrile illness during an epidemic of dengue fever in Lahore, Pakistan," Merit Research Journal of Medicine and Medical Sciences, vol. 3, pp. 69–73, 2015. View at Google Scholar 

[5]         M. Rauf, "Outbreak of chikungunya in Pakistan," Lancet Infectious Diseases, vol. 17, p. 258, 2017. View at Google Scholar 

[6]         C. Angela, H. Zhisheng, K. S. O. Edward, C. Jin-miao, D. Frederico, J. C. K. Dyan, B. Timothy, Y. Henry, R. Laurent, and L. Yee-Sin, "Ng; Persistent Arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor," Journal of Infectious Diseases, vol. 203, pp. 149-157, 2011. View at Google Scholar | View at Publisher

[7]         D. Hawman, K. Stoermer, S. Montgomery, P. Pal, L. Oko, M. Diamond, and T. Morrison, "Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response," Journal of Virology, vol. 87, pp. 13878-13888, 2013. View at Google Scholar | View at Publisher

[8]         R. Katti, P. R. Shahapur, and K. L. Udapudi, "Impact of Chikungunya virus infection on oral health status: An observational study," Indian Journal of Dental Research, vol. 22, p. 613, 2011. View at Google Scholar | View at Publisher

[9]         D. Mourya and P. Yadav, "Vector biology of dengue and chikungunya viruses," Indian Journal of Medical Research, vol. 124, pp. 475-480, 2006. View at Google Scholar 

[10]       I. Sam, B. Kümmerer, Y. Chan, P. Roques, C. Drosten, and B. S. Abu, "Updates on Chikungunya epidemiology, clinical disease, and diagnostics," Vector-Borne and Zoonotic Diseases, vol. 15, pp. 223-230, 2015. View at Google Scholar | View at Publisher

[11]       F. Burt, M. Rolph, N. Rulli, and S. Mahalingam, "Chikungunya: a re-emerging virus," Lancet, vol. 379, pp. 662-71, 2012.View at Google Scholar | View at Publisher

[12]       M. Robinson, "An epidemic of virus disease in southern province, Tanganyika territory in 1952, 53. Clinical features," Transactions of The Royal Society of Tropical Medicine and Hygiene, vol. 49, pp. 28-32, 1955. View at Google Scholar | View at Publisher

[13]       M. Jadhav, M. Namboodripad, R. Carman, D. Carey, and R. Myers, "Chikungunya disease in infants and children in vellore: A report of clinical and haematological features of virologically proved cases," Indian Journal of Medical Research, vol. 53, pp. 764-776, 1965. View at Google Scholar 

[14]       K. Thiruvengadam, V. Kalyansundaram, and J. Rajgopal, "Clinical and pathological studies on chikungunya fever in madras city," Indian Journal of Medical Research, vol. 53, pp. 729-744, 1965. View at Google Scholar 

[15]       F. Rodrigues, M. Patankar, K. Banarjee, P. Bhatt, M. Goverdhn, and K. Pavri, "Etiology of the 1965 epidemic of febrile illness in Nagpur city, Maharashtra State, India," Bulletin of the World Health Organization, vol. 46, pp. 173-179, 1972. View at Google Scholar 

[16]       P. Kaur, M. Ponniah, M. Murhekar, V. Ramachandran, R. Ramachandran, and H. Raju, "Chikungunya outbreak, South India, 2006," Emerging Infectious Diseases, vol. 14, pp. 1623-1625, 2008. View at Google Scholar | View at Publisher

[17]       S. Suryawanshi, A. Dube, R. Khadse, S. Jalgaonkar, P. Sathe, and S. Zawar, "Clinical profile of chikungunya fever in patients in a tertiary care centre in Maharashtra, India," Indian Journal of Medical Research, vol. 129, pp. 438-441, 2009. View at Google Scholar 

[18]       G. Borgherini, P. Poubeau, F. Staikowsky, M. Lory, N. Moullec, and J. Becquart, "Outbreak of chikungunya on reunion Island: Early clinical and laboratory features in 157 adult patients," Clinical Infectious Diseases, vol. 44, pp. 1401-1407, 2007. View at Google Scholar | View at Publisher

[19]       A. O. A. Sanae and C. Bernard, "Arthritis after infection with Chikungunya virus," Best Practice & Research Clinical Rheumatology, vol. 25, pp. 337-346, 2011. View at Google Scholar | View at Publisher

[20]       A. Kennedy, J. Fleming, and L. Soloman, "Chikungunya viral arthropathy: A clinical description," Journal of Rheumatology, vol. 7, pp. 231–236, 1980. View at Google Scholar 

No any video found for this article.
Besalat Hussain , Fatima Mushtaq , Naima Javed , Affa Khan (2018). An Observational Study Evaluating the Impact of Chikungunya Virus Infection on Oral Cavity and Temporomandibular Joint. International Journal of Medical and Health Sciences Research, 5(1): 18-24. DOI: 10.18488/journal.9.2018.51.18.24
Over a past few years, a very limited number of studies researched whether the chikungunya virus affects the oral cavity in addition to pronounced symptoms in extremities but on literature review different studies were found to have different conclusions. Thus an Observational Study was conducted evaluating the impact of Chikungunya Virus Infection on Oral Cavity and Temporomandibular Joint. This was a cross sectional study having a self-designed questionnaire, descriptive and associative tests were run for Data analysis using SPSS. Out of 527 tested, 204 patients were found seropositive and 135 were selected for data analysis on their consent (N 135). Pain and burning sensation of mouth (71.1%), discomfort in mouth opening (65.9%), Bleeding gums (53.3%), and taste aversion (50.3%) were the most common complaints followed by Inability to chew food (48.1%), Discomfort in swallowing (35.5%), Halitosis (34.8%) and tenderness over TMJ (30.4%). The study significantly recorded pain, discomfort and bleeding gums intraorally. Pain, tenderness and decreased efficiency of temporomandibular joint were also noted.
Contribution/ Originality
This study contributes in the existing literature of Chikungunya virus infection. Interval estimation statistical method is used. It is one of very few studies which have investigated impact of Chikungunya Virus Infection on Oral Cavity and Temporomandibular Joint and concluded it to be quite painful and uncomfortable to bear causing burning gums, limiting speech, decreased chewing ability, altering taste perception, TM-joint and muscles tenderness and difficulty in food swallowing.

Comparison of Psychiatric Comorbidity and Quality of Life (QOL) in Persons with Tuberculosis and People Living with HIV in South-South Nigeria

Pages: 1-17
2018Find References

Finding References


Comparison of Psychiatric Comorbidity and Quality of Life (QOL) in Persons with Tuberculosis and People Living with HIV in South-South Nigeria

Search :
Google Scholor
Search :
Microsoft Academic Search
Cite

DOI: 10.18488/journal.9.2018.51.1.17

Nkporbu A. K. , ANUSIEM O.O. , AGOGBUO M. O.

Export to    BibTeX   |   EndNote   |   RIS

[1]          World Health Organization Global Tuberculosis Report, Retrieved from http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 . [Accessed Nov.18/2016], 2016.

[2]          R. A. Van, S. Sengupta, P. Pungrassami, Q. Balthip, S. Choonuan, and Y. Kasetjaroen, "Measuring stigma associated with tuberculosis and HIV/AIDS in Southern Thailand: Exploratory and confirmatory factor analyses of two new scales," Tropical Medicine & International Health, vol. 13, pp. 21–30, 2008. View at Google Scholar | View at Publisher

[3]          Z. Gohain and M. Halliday, "Internalized HIV-stigma, mental health, coping and perceived social support among people living with HIV/AIDS in Aizawl  District—A pilot study," Psychology, vol. 5, pp. 1794–1812, 2014. View at Google Scholar | View at Publisher

[4]          G. M. Herek and J. P. Capittanio, "Public reactions to AIDS in the United States: A second decade of stigma," Archive of American Journal of Public Health, vol. 83, pp. 574-577, 1993. View at Google Scholar | View at Publisher

[5]          G. Green, "Attitudes towards people with HIV: Are they as stigmatizing as people with HIV perceive them to be?," Social Science & Medicine, vol. 41, pp. 557-568, 1995. View at Google Scholar | View at Publisher

[6]          R. Parker and P. Aggleton, "HIV and AIDS related stigma and discrimination: A conceptual framework and implications for action," Social Science & Medicine, vol. 57, pp. 13-24, 2003. View at Google Scholar | View at Publisher

[7]          M. E. Kunik, K. Roundy, and C. Veazey, "Surprisingly high prevalence of anxiety and depression in chronic breathing disorders," Chest, vol. 127, pp. 1205–1211 2005. View at Google Scholar | View at Publisher

[8]          S. Masumoto, T. Yamamoto, A. Ohkado, S. Yoshimatsu, A. G. Querri, and Y. Kamiya, "Prevalence and associated factors of depressive state among pulmonary tuberculosis patients in Manila, the Philippines," International Journal of Tuberculosis and Lung Disease, vol. 18, pp. 174–179, 2014. View at Google Scholar | View at Publisher

[9]          T. R. Chandrashekar, P. Denzil, K. Rajendrkumar, A. R. Shantha, R. H. Bhagyashri, and A. V. Joshi, "A study of psychiatric morbidity among patients suffering from pulmonary tuberculosis," Medicine Legal Update, vol. 12, pp. 26-29, 2012.

[10]        A. S. Srivastava, N. A. Ramdinee, S. C. Matah, M. N. Tripathi, B. Pandit, and J. S. Yadav, "Psychiatric morbidities in patients with pulmonary tuberculosis," Dysphrenia, vol. 5, pp. 133–137, 2014. View at Google Scholar 

[11]        L. Campos, M. Guimarães, and R. Remien, "Anxiety and depression symptoms as risk factors for nonadherence to antiretroviral therapy in Brazil," AIDS and Behavior, vol. 14, pp. 289–299, 2011.

[12]        B. A. Issa, A. D. Yussuf, and S. I. Kuranga, "Depression comorbidity among patients with tuberculosis in a university teaching hospital outpatient clinic in Nigeria," Mental Health in Family Medicine, vol. 6, pp. 133-138, 2009. View at Google Scholar 

[13]        J. P. De Santis, E. Provencio-Vasquez, H. J. Mata, and J. Martinez, "Depression and co-occurring health determinants of hispanic men with HIV infection in the U.S. Mexico border region: A pilot study," Journal of Social Service Research, vol. 42, pp. 305-312, 2016. View at Google Scholar | View at Publisher

[14]        D. Eshetu, S. Woldeyohannes, M. Alemayehu, G. Techane, M. Tegegne, and K. Dagne, "Prevalence of depression and associated factors among HIV/AIDS Patients attending ART Clinic at Debrebirhan referral hospital, North Showa, Amhara Region, Ethiopia," American Journal of Community Psychology, vol. 2, pp. 101–108, 2014.

[15]        M. Bhate and S. Munjal, "Prevalence of depression in people living with HIV/AIDS undergoing ART and factors associated with it," Journal of Clinical and Diagnostic Research, vol. 8, pp. 1–4, 2014. View at Google Scholar 

[16]        H. Berhe and A. Bayray, "Prevalence of depression and associated factors among people livingwith HIV/AIDSI in Tigray, Ethiopia. North Ethiopia: A crosssectional rosssectional hospital based study," International Journal of Pharmaceutical Sciences and Research, vol. 4, pp. 765–775, 2013.

[17]        A. Belete, G. Andaregie, M. Tareke, T. Birhan, and T. Azale, "Prevalence of anxiety and associated factors among people living with HIV/AIDS at Debretabor general hospital Anti Retro Viral clinic Debretabor, Amhara, Ethiopia," American Journal of Psychiatry and Neuroscience, vol. 2, pp. 109–114, 2014. View at Google Scholar | View at Publisher

[18]        J. Boardman, H. Petrusthkin, and E. Ovuga, "Psychiatric disorders in HIV positive individuals in urban Uganda," British Journal of Psychiatry, vol. 29, pp. 455-460, 2005. View at Google Scholar | View at Publisher

[19]        S. Aamir and Aisha, "Comorbid anxiety and depression among TB patients," Journal of College of Physicians and Surgeon Pakistan, vol. 20, pp. 703-704, 2010.

[20]        M. O. Husain, S. P. Dearman, I. B. Chaudhry, N. Risvi, and W. Wwaheed, "The relationship between anxiety, depression and illness perception in TB patients in Pakistan," Clinical Practice and Epidemiology in Mental Health, vol. 4, pp. 1-5, 2008. View at Google Scholar 

[21]        O. Ige and V. Lasebikan, "Prevalence of depression in tuberculosis patients in comparison to non-tuberculosis family contacts visiting the DOTS clincs in tertiary care hospital and its correlation with disease pattern," Mental Health in Family Medicine, vol. 8, pp. 235–241, 2011. View at Google Scholar 

[22]        TB, "TB statistic-global record of high burden, national TB statistic, global tuberculosis control, WHO Geneva." Retrieved from www.who.int/tb/publication/globalreport/TBfacts.org, 2015.

[23]        World Health Organization: Promoting Mental Health, Concepts, emerging evidence, practice. Geneva, Switzerland: WHO, 2004.

[24]        A. Obadeji, A. Ogunlesi, and T. Adebowale, "Prevalence and predictors of depression in people living with HIV/AIDS attending an outpatient clinic in Nigeria," Iranian Journal of Psychiatry and Behavioral Sciences, vol. 8, pp. 26–31, 2014. View at Google Scholar 

[25]        N. Nebhinanl, S. Mattoo, and A. Wanchu, "Psychiatric morbidity in HIV-positive subjects: A study from India," Psychosomatic Research, vol. 70, pp. 449-454, 2011. View at Google Scholar | View at Publisher

[26]        K. Micheline, "Prevalence of depression among TB patients attending tuberculosis clinc at Mbagatji District Hospital Nairibi Kenya," Clinical Psychology Dissertation, vol. 6, pp. 15–23, 2011.

[27]        C. Pedersen, H. J. Kolmos, and J. O. Nielsen, "Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection," Ugeskr Laeger, vol. 159, pp. 1233–1238, 1997. View at Google Scholar 

[28]        A. Deribew, M. Tesfaye, Y. Hailmichael, L. Apers, G. Abebe, and L. Duchateau, "Common mental disorders in TB/HIV co-infected patients in Ethiopia," BMC Infectious Diseases, vol. 10, pp. 201-208, 2010. View at Google Scholar | View at Publisher

[29]        WHO, Health organization global tuberculosis control: Surveillance planning, financing. WHO report 2003. Geneva: WHO; (WHO/CDS/TB/2003.316), 2003.

[30]        A. J. Trenton and G. W. Currier, "Treatment of comorbid tuberculosis and depression," Primary Care Companion Journal of Clinical Psychiatry, vol. 3, pp. 236-243, 2001. View at Google Scholar | View at Publisher

[31]        P. Aniebue and K. Okonkwo, "Prevalence of depressive symptoms amongst pulmonary tuberculosis patients at the University of Nigeria Teaching Hospital, Enugu," International Journal of Medicine and Health Development, vol. 11, pp. 120-124, 2006. View at Google Scholar 

[32]        W. Sun, M. Wu, P. Qu, C. Lu, and L. Wang, "Psychological well-being of people living with HIV/AIDS under the new epidemic characteristics in China and the risk factors: A population-based study," International Journal of Infectious Diseases, vol. 28, pp. 147–52, 2014. View at Google Scholar | View at Publisher

[33]        A. F. Angelino and G. J. Treisman, "Management of psychiatric disorders in patients infected with human immunodeficiency virus," Clinical Infectious Diseases, vol. 33, pp. 847–856, 2001. View at Google Scholar | View at Publisher

[34]        V. Kumar and W. Encinosa, "Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients," Psychiatric Quarterly, vol. 80, pp. 131-141, 2009. View at Google Scholar | View at Publisher

[35]        B. W. Pence, "Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy," Journal of Acquired Immune Deficiency Syndromes, vol. 44, pp. 159–166, 2007. View at Google Scholar | View at Publisher

[36]        P. Bolduc, N. Roder, E. Colgate, and S. H. Cheeseman, "Care of patients with HIV infection: Primary care," FP Essent, vol. 443, pp. 31-42, 2016. View at Google Scholar 

[37]        Practice, "Practice guideline for the treatment of patients with HIV/AIDS. Work Group on HIV/AIDS. American psychiatric association," American Journal of Psychiatry, vol. 157, pp. 1-62, 2000.

[38]        I. M. Magodoro, T. M. Esterhuizen, and T. Chivese, "A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe," BMC Research Notes, vol. 9, pp. 379-389, 2016. View at Google Scholar | View at Publisher

[39]        C. A. Stanton, D. R. Keith, D. E. Gaalema, J. Y. Bunn, and N. J. Doogan, "Trends in tobacco use among US adults with chronic health conditions: National survey on drug use and health 2005-2013," Preventive Medicine Personally Identifiable Information, vol. 92, pp. 160-168, 2016. View at Google Scholar | View at Publisher

[40]        M. Atif, S. A. S. Sulaiman, A. A. Shafie, M. Asif, M. K. Sarfraz, and H. C. Low, "Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: A follow-up study," Health and Quality of Life Outcomes, vol. 12, pp. 19-30, 2014. View at Google Scholar | View at Publisher

[41]        H. Jia, C. R. Uphold, S. Wu, K. Reid, and K. Findley, "Health-related quality of life among men with HIV infection: Effects of social support, coping and depression," AIDS Patients Care STDS, vol. 18, pp. 594-603, 2004. View at Google Scholar | View at Publisher

[42]        C. Liu, l. Johnson, D. Ostrow, A. Silvestre, and B. Visscher, "Predictors of lower quality of life in the HAART Era among HIV infected men," Journal of Acquired Immune Deficiency Syndromes, vol. 24, pp. 470-477, 2006. View at Google Scholar | View at Publisher

[43]        S. Low-Beer, K. Chan, E. Wood, B. Yip, J. S. Montaner, M. V. O Shaughnessy, and R. S. Hogg, "Health related quality of life among persons with HIV after the use of protease inhibitors," Quality of Life Research, vol. 9, pp. 941-949, 2000. View at Google Scholar 

[44]        M. A. Testa and W. R. Lenderking, Quality of life considerations in AIDS clinical trials in: Pinkelsten D.M, Schoenfeld, D.A, Eds. AIDS clinical trails guidelines for design and analysis. New York: Wiley-Liss, 1995.

[45]        P. S. Chandra, V. Deepthi, K. R. Jairam, and T. Thomas, "Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons," Journal of Psychosomatic Research, vol. 54, pp. 199-203, 2003. View at Google Scholar | View at Publisher

[46]        J. Louw, K. Peltzer, P. Naldoo, G. Matseke, G. Mchunu, and B. Tutshana, "Quality of life among TB patients TB Retreatment and or TB-HIV Co-infected in primary public health care patient in 3 district in South Africa," Health Quality of Life Outcomes, vol. 10, pp. 77-85, 2012. View at Google Scholar | View at Publisher

[47]        N. Guo, F. Marra, and C. Marra, "Measuring health-related quality of life in tuberculosis: A systematic review," Health Qual Life Outcomes, vol. 7, pp. 1-9, 2009. View at Google Scholar 

[48]        W. R. Lenderking, R. D. Gelber, and D. L. Cotton, "Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection," New England Journal of Medicine, vol. 330, pp. 738-743, 1994. View at Google Scholar | View at Publisher

[49]        A. Deribew, M. Tesfaye, Y. Hailmichael, N. Negussu, S. Daba, and A. Wogi, "Tuberculosis and HIV co-infection: Its impact on quality of life," Health and Quality of Life Outcomes, vol. 7, pp. 105-112, 2009. View at Google Scholar | View at Publisher

[50]        A. Sarah, N. Samar, H. H. Abu-Saad, and D. J. M. Jocelyn, "Quality of life in people living with HIV/AIDS in Lebanon," AIDS Care, vol. 22, pp. 687–696, 2010. View at Google Scholar | View at Publisher

[51]        C. D. Sherbourne, "Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers," Archives of General Psychiatry, vol. 53, pp. 889–895, 1996. View at Google Scholar | View at Publisher

[52]        E. D. Riley, "Basic subsistence needs and overall health among human immunodeficiency virus-infected homeless and unstably housed women," American Journal of Epidemiology, vol. 174, pp. 515–522, 2011. View at Google Scholar | View at Publisher

[53]        A. Baba, D. Abdullah, and I. Suleiman, "Depression co-morbidity among patients with Tuberculosis in a university teaching hospital outpatient clinic in Nigeria," Mental Health Problems in Family Medicine, vol. 6, pp. 133–138, 2009.

[54]        C. Mathers and D. Loncar, "Projections of global mortality and burden of disease from 2002 to 2030," PLOS Medicine, vol. 3, p. e442, 2006. View at Google Scholar | View at Publisher

[55]        World Health Organization, Global tuberculosis control. WHO report 2013. Geneva: WHO, 2013.

[56]        WHO, World health organization global tuberculosis control: Surveillance planning, financing. WHO report 2003. Geneva: WHO; (WHO/CDS/TB/2003.316), 2003.

[57]        J. Cook, D. Grey, and J. Burke, "Depressive symptoms and AIDS-related mortality among a multiside cohort of HIV-positive women," American Journal of Public Health, vol. 94, pp. 1133-1140, 2004. View at Google Scholar | View at Publisher

[58]        D. Gwatkin, M. Guillot, and P. Heuveline, "The burden of disease among the global poor," Lancet, vol. 354, pp. 586-589, 2000.

[59]        World Health Organization, "Global Tuberculosis Report." Retrieved from http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 . [Accessed Nov.18/2016], 2016.

[60]        International, International union against tuberculosis and lung disease tuberculosis guide for low income countries (5e). Paris: International Union Against Tuberculosis and Lung Disease, 2000.

[61]        G. Moussas, A. Tselebis, and A. Karkanias, "A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases," Annals of General Psychiatry, vol. 7, pp. 7-11, 2008. View at Google Scholar | View at Publisher

[62]        I. O. Aydin and A. Uluşahin, "Depression, anxiety comorbidity, and disability in TB and chronic ob-structive pulmonary disease patients: Applicability of GHQ-12," General Hospital Psychiatry, vol. 23, pp. 77–83, 2001. View at Google Scholar | View at Publisher

[63]        M. S. Westaway and L. Wolmarans, "Depression and self-esteem: Rapid screening for depression in black, low literacy, hospitalized TB patients," Social Science & Medicine, vol. 35, pp. 1311–1315 1992. View at Google Scholar | View at Publisher

[64]        H. S. Aghanwa and G. E. Erhabor, "Demographic/socioeconomic factors in mental disorders associated with TB in South West Nigeria," Journal of Psychosomatic Research, vol. 45, pp. 353–360, 1998. View at Google Scholar | View at Publisher

[65]        L. Swarn, "Correlation with duration and depression in TB patients in rural Jaipur District Hospital," International Journal of Pharma and Bio Sciences, vol. 2, pp. 263–267, 2011. View at Google Scholar 

[66]        H. L. McQuistion, P. Colson, and R. Yankowitz, "Tuberculosis infection among people with severe mental illness," Psychiatric Services, vol. 48, pp. 833–835, 1997. View at Google Scholar | View at Publisher

[67]        C. Longenecker, N. Funderburg, Y. Jiang, S. Debanne, N. Storer, D. Labbato, and G. McComsey, "Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals," HIV Medicine, vol. 14, pp. 385–390, 2013. View at Google Scholar | View at Publisher

[68]        O. Dalgard, C. Dowrick, V. Lehtinen, J. Vazquez-Barquero, P. Casey, and G. Wilkinson, "Negative life events, social support and gender difference in depression," Social Psyciatry and Psychiatric Epidemiology, vol. 41, pp. 444-451, 2006. View at Google Scholar 

[69]        P. Vega, A. Sweetland, J. Acha, H. Castillo, D. Guerra, and F. M. C. Smith, "Psychiatric issues in the management of patients with multidrug-resistant tuberculosis," International Journal of Tuberculosis and Lung Disease, vol. 8, pp. 749-59, 2004. View at Google Scholar 

[70]        E. Manoharam, K. R. John, A. Joseph, and K. S. Jacob, "Psychiatric morbidity, patients' perspectives of illness and factors associated with poor medication compliance among the tuberculosis in Vellore, South India," Indian Journal of Tuberculosis, vol. 48, pp. 77-80, 2001. View at Google Scholar 

[71]        K. Donelan, C. A. Hill, and C. Hoffman, "Challenged to care: Informal caregivers in a changing health system," Health Affairs, vol. 21, pp. 222–231 2002. View at Google Scholar | View at Publisher

[72]        M. De Hert, D. Cohen, J. Bobes, M. Cetkovich-Bakmas, S. Leucht, and D. M. Ndetei, "Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level," World Psychiatry, vol. 10, pp. 138-151, 2011. View at Google Scholar | View at Publisher

[73]        R. M. Hirschfeld, "The comorbidity of major depression and anxiety disorders: Recognition and management in primary care," Primary Care Companion to the Journal of Clinical Psychiatry, vol. 3, pp. 244–254, 2001. View at Google Scholar | View at Publisher

[74]        W. Katon, E. H. Lin, and K. Kroenke, "The association of depression and anxiety with medical symptom burden in patients with chronic medical illness," General Hospital Psychiatry, vol. 29, pp. 147–155, 2007. View at Google Scholar | View at Publisher

[75]        J. Barroso, "Physiological and psychosocial factors that predict HIV-related fatigue," AIDS and Behavior, vol. 14, pp. 1415–1427, 2010 View at Google Scholar | View at Publisher

[76]        M. Dew, J. Becker, and J. Sanchez, "Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation," Psychological Medicine, vol. 27, pp. 395-409, 1997. View at Google Scholar | View at Publisher

[77]        S. Rueda, J. Raboud, C. Mustard, A. Bayoumi, J. Lavis, and S. Rourke, "Employment status is associated with both physical and mental health quality of life in people living with HIV," AIDS Care, vol. 23, pp. 435–443, 2011. View at Google Scholar | View at Publisher

[78]        P. Calvetti, G. Giovelli, G. Gauer, and J. Moraes, "Psychosocial factors associated with adherence to treatment and quality of life in people living with HIV/AIDS in Brazil," Brazilian Journal of Psychiatry, vol. 63, pp. 8–15, 2014. View at Google Scholar | View at Publisher

[79]        D. A. Perlick, R. A. Rosenheck, J. F. Clarkin, J. A. Sirey, J. Salahi, E. L. Struening, and B. G. Link, "Stigma as a barrier to recovery: Adverse effects of perceived stigma on social adaptation of persons diagnosed with bipolar affective disorder," Psychiatric Services, vol. 52, pp. 1627-1632, 2001. View at Google Scholar | View at Publisher

[80]        B. J. Turner, "Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons," Journal of General Internal Medicine, vol. 16, pp. 625–633, 2001. View at Google Scholar | View at Publisher

[81]        E. G. Bing, "Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States," Archives of General Psychiatry, vol. 58, pp. 721–728, 2001. View at Google Scholar | View at Publisher

[82]        L. R. Pacek, P. T. Harrell, and S. S. Martins, "Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals," American Journal on Addictions, vol. 23, pp. 582-590, 2014a.

[83]        U. Ibragimov, J. A. Harnisch, E. J. Nehl, N. He, and T. Zheng, "Estimating self-reported sex practices, drug use, depression, and intimate partner violence among MSM in China: A comparison of three recruitment methods," AIDS Care, vol. 1, pp. 1-7, 2016.

[84]        N. Sacktor, R. Lyles, and R. Skolasky, "HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort study, 1990-1998," Neurology, vol. 56, pp. 257–260, 2001. View at Google Scholar | View at Publisher

[85]        R. K. Heaton, D. B. Clifford, D. R. J. Franklin, S. P. Woods, C. Ake, and F. Vaida, "HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter study," Neurology, vol. 75, pp. 2087-2096, 2010. View at Google Scholar | View at Publisher

[86]        K. Robertsona, C. Bayonb, J. Molinac, P. McNamarae, C. Reschf, and J. Muñoz- Morenog, "Screening for neurocognitive impairment, depression, and anxiety in HIV infected patients in Western Europe and Canada," AIDS Care, vol. 26, pp. 1555-1561, 2014. View at Google Scholar | View at Publisher

[87]        F. E. Odiase, O. A. Ogunrin, and A. Ogunniyi, "Memory performance in HIV/AIDS – a prospective case control study," Canadian Journal of Neurological Sciences, vol. 34, pp. 154-159, 2007. View at Google Scholar | View at Publisher

[88]        S. de Almeida, F. Barbosa, R. Kamat, A. de Pereira, and S. Raboni, "Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil," Journal of Neurovirology, vol. 22, pp. 789-798, 2016. View at Google Scholar | View at Publisher

[89]        J. Badiee, D. J. Moore, J. H. Atkinson, F. Vaida, M. Gerard, and N. A. Duarte, "Lifetime suicidal ideation and attempt are common among HIV+ individuals," Journal of Affective Disorders, vol. 136, pp. 993-999, 2012. View at Google Scholar | View at Publisher

[90]        J. Neuenburg, H. Brodt, and B. Herndier, "HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy," Journal of Acquired Immune Deficiency Syndromes, vol. 31, pp. 171–177, 2002. View at Google Scholar | View at Publisher

[91]        D. De Ronchi, I. Faranca, P. Forti, G. Ravaglia, M. Borderi, R. Manfredi, and V. Volterra, "Development of acute psychotic disorders and HIV-1 infection," International Journal of Psychiatry in Medicine, vol. 30, pp. 173-183, 2000. View at Google Scholar | View at Publisher

[92]        A. Martinez, D. Israleski, and C. Walker, "Posttraumatic stress disorders in women attending human immunodeficiency virus outpatient clinics," AIDS Patient Care STDS, vol. 16, pp. 283-289, 2002. View at Google Scholar | View at Publisher

[93]        B. O. Olley, M. D. Zeier, S. Seedat, and D. J. Stein, "Posttraumatic stress disorder among recently diagnosed patients with HIV/AIDS in South Africa," AIDS Acre, vol. 17, pp. 550-557, 2005. View at Google Scholar | View at Publisher

[94]        D. L. Delahanty, L. M. Bogart, and J. L. Figler, "Posttramautic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals," AIDS Care STDs, vol. 16, pp. 247-260, 2004. View at Google Scholar | View at Publisher

[95]        S. A. Safren, B. S. Gershuny, and E. Hendriksen, "Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties," AIDS Patients Care STDs, vol. 17, pp. 657-664, 2003. View at Google Scholar | View at Publisher

[96]        S. Katze and J. S. Nevid, "Risk factors associated with posttraumatic stress disorder symptomatology in HIV-infected women " AIDS Patients Care STD, vol. 19, pp. 110-120, 2005. View at Publisher

[97]        P. S. Chandra, S. Deepthivarma, and V. Manjula, "Disclosure of HIV infection in South India: Patterns, reasons and reactions," AIDS Care, vol. 15, pp. 207-215, 2003 View at Google Scholar | View at Publisher

[98]        T. De Bruyn, HIV/AIDS and 1. Discrimination, 2. Stigma and discrimination: Definitions and concepts. Ottawa: Canadian HIV/AIDS Legal Network and the Canadian AIDS Society, 1999.

[99]        A. A. Alonzo and S. N. R. Reynolds, "HIV and AIDS: An exploration and elaboration of a stigma trajectory," Social Science & Medicine, vol. 41, pp. 303-315, 1995. View at Google Scholar 

[100]      A. Levy, F. Laska, A. Abelhauser, J. E. Delfraissy, C. Goujard, and F. Bowe, "Disclosure of HIV seropositivity," Journal of Clinical Psychology, vol. 55, pp. 1041-1049, 1999. View at Google Scholar | View at Publisher

[101]      S. Bharat, "HIV/AIDS related discrimination, stigmatization and Denial in India- a study based in Mumbai and Bangalore (Sponsored by UNAIDS, Geneva, TISS Mumbai) UNAIDS, Geneva," 1999.

[102]      N. Mawar and R. S. Paranjape, "Live and let live: Acceptance of people living with HIV/AIDS in an era where stigma and discrimination persist," ICMR Bull, vol. 32, pp. 105-114, 2002. View at Google Scholar 

[103]      B. Spire, S. Duran, M. Souville, C. Leport, F. Rafll, and J. Moatll, "APROCO cohort study group. Adherence to HAART in HIV infected patients: From a predictive to a dynamic approach," Social Sale Media, vol. 54, pp. 1481-1496, 2002.

[104]      M. Chesney, J. lkovics, F. Hecht, O. Skips, and L. Rabibkin, "Adherence: A necessity for successful HIV combination therapy," AIDS, vol. 13, pp. 271-278, 1999. View at Google Scholar 

[105]      N. Singh, S. Bemen, and S. Swindells, "Adherence of HIV-infected patients to antiretroviral therapy," Clinical Infectious Diseases, vol. 20, pp. 824-830, 1999. View at Google Scholar 

[106]      I. Grassi, A. Right, L. Sighinolfi, S. Makoui, and F. Ghinelli, "Coping styles and psychosocial-related variables in HlV-infected patients," Psychcomatics, vol. 39, pp. 350-359, 1998. View at Google Scholar | View at Publisher

[107]      T. Wolf, P. Balson, and E. Morse, "Relationship of coping style to affective state and perceived social support in asymptomatic and symptomatic HIV-Infected persons: Implications for clinical management" Journal of Clinical Psychiatry, vol. 52, pp. 171-173, 1991. View at Google Scholar 

[108]      W. Nichotaon and B. Long, "Self-esteem, social support, internalized homophiobia, and coping strategies of HIV+ gay men," Journal of Consulting and Clinical Psychology, vol. 50, pp. 873-876, 1990. View at Google Scholar | View at Publisher

[109]      V. Gordilio, J. Del Amo, V. Sorisno, and J. Gonzalez-Lahoz, "Sociodemographic and  psychological variables influencing adherence to antiretroviral therapy," AIDS, vol. 13, pp. 1763-1769, 1999. View at Google Scholar | View at Publisher

[110]      W. C. Green, "The molecular biology of HIV-1 infection," N Engineering Medical, vol. 324, pp. 308-316, 1991.

[111]      Y. Rivera-Rivera, F. Vázquez-Santiago, E. Albino, M. Sánchez, and V. Rivera-Amill, "Impact of Depression and Inflammation on the progression of HIV Disease," Journal of Clinical and Cellular Immunology, vol. 7, pp. 423-439, 2016. View at Google Scholar | View at Publisher

[112]      J. Leserman, "HIV disease progression: Depression, stress, and possible mechanisms," Biological Psychiatry, vol. 54, pp. 295–306, 2003. View at Google Scholar | View at Publisher

[113]      J. Atkinson and I. Grant, "Natural history of neuropsychiatric manifestations of HIV disease," Psychiatric Clinics of North America, vol. 17, pp. 17-33, 1994. View at Google Scholar 

[114]      M. Vanderpool, "Resilience: A missing link in our understanding of survival," Harvard Review of Psychiatry, vol. 10, pp. 302–306, 2002. View at Google Scholar |

No any video found for this article.
Nkporbu A. K. , ANUSIEM O.O. , AGOGBUO M. O. (2018). Comparison of Psychiatric Comorbidity and Quality of Life (QOL) in Persons with Tuberculosis and People Living with HIV in South-South Nigeria. International Journal of Medical and Health Sciences Research, 5(1): 1-17. DOI: 10.18488/journal.9.2018.51.1.17
BACKGROUND: Tuberculosis and HIV are two chronic infective medical diseases commonly associated with psychiatric co-morbidity, which further affect the quality of life of the sufferers. AIM: The study was to determine and compare the relationship between psychiatric co-morbidity and quality of life in persons with tuberculosis and PLWHIV. METHODOLOGY: Two hundred and thirty subjects living with HIV and 140 subjects with tuberculosis were recruited. Those with clinically chronic conditions, or comorbid medical condition and treatment Resistant tuberculosis were excluded. Subjects were further administered with the study’s instruments including the socio-demographic questionnaire, GHQ-12, the brief version of the WHO Quality of Life instrument (WHOQOL-Bref) and WHO Composite International Diagnostic Interview (WHO CIDI). Results were presented via descriptive and analytical methods. RESULTS: The study found a prevalence of psychiatric co-morbidity of 19.8% among PLWHIV and 28.4% among subjects with tuberculosis (p = 0.004). For the PLWHIV, domain scores for quality of life were as follows; 60.71±15.57, 62.34±26.32, 61.57±25.04, 55.15±14.00 and 65.81±21.84 while tuberculosis was 50.97±13.87, 57.22±46.36, 54.51±45.04, 50.01±15.10 and 49.34±21.84 (p = 0.001) for physical, psychological, social relationship, environment domains and general health facet respectively. Furthermore, presence of psychiatric comorbidity significantly inversely correlated with quality of life among persons with both medical diseases. CONCLUSION: The study found a statistically significant higher prevalence of psychiatric co-morbidity and lower quality of life among the subjects with tuberculosis compared with PLWHIV. Findings suggest strongly that in managing patients with these conditions, attention should be paid to their mental health and subjective quality of life.
Contribution/ Originality
This study contributes in the existing literature about the sufferers of chronic infectious medical diseases and their vulnerability to psychiatric co-morbidity. The study documents explanations as to why some chronic medical conditions may show slow response to instituted management. The study uses new estimation methodology of Quality of life measurement and demonstrates the direct relationship between psychiatric co-morbidity and quality of life. Finally, the study contributes to logical analysis and emphasis that evaluation of patients suffering from chronic medical diseases must be holistic enough to include their mental wellbeing.